Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-018-3645-1
Abstract: ObjectiveThe aim of this study was to explore the tolerance, variability, and pharmacokinetics (PK) of bevacizumab biosimilars (MIL60, BAT1706, IBI305) in Chinese healthy male subjects.MethodsThis randomized, double-blind, two-arm, parallel studies included three separate investigations, which… read more here.
Keywords: bevacizumab biosimilars; chinese healthy; bevacizumab; pharmacokinetics bevacizumab ... See more keywords